02 November 2022 |
| 08:50-09:00 | | Welcome and IntroductionChair(s):Dinesh Giri, BSPED CME Officer (Bristol, UK)Hall 1A |
| 09:00-10:00 | | CME Session 1Chair(s):Dinesh Giri (Bristol, UK) & Georgina Williams (Cardiff, UK)Hall 1A |
| 09:00 | | Endocrine approach of a patient with late effectsElizabeth Crowne (Bristol, UK) |
| 09:30 | | Genetic approach to short statureHelen L Storr (Queen Mary University London (QMUL) and Barts Health Trust, London, UK) |
| 10:00-10:30 | | CME Case Presentations 1Chair(s):Dinesh Giri (Bristol, UK) & Georgina Williams (Cardiff, UK)Hall 1A |
| 10:15 | OC1.1 | Defects in QSOX2, a novel regulator of STAT5B nuclear import and transcriptional activity, lead to severe post-natal growth restrictionAvinaash V Maharaj (London, UK) |
| 10:00 | OC1.2 | A rare case of short stature with high total Insulin Like Growth Factor 1 (IGF-1) and a novel pregnancy-associated plasma protein A2 (PAPPA2) gene mutationSumana Chatterjee (Bristol, UK) |
| 10:30-11:00 | | BreakHall 1C & 1D |
| 11:00-12:00 | | CME Session 2Chair(s):Dinesh Giri (Bristol, UK) & Elspeth Ferguson (Sheffield, UK)Hall 1A |
| 11:00 | | Neonatal DiabetesSarah Flanagan (Exeter, UK) |
| 11:30 | | An approach to hypo/hypercalcemiaRaja Padidela (Manchester, UK) |
| 12:00-12:30 | | CME Case Presentations 2Chair(s):Dinesh Giri (Bristol, UK) & Elspeth Ferguson (Sheffield, UK)Hall 1A |
| 12:00 | OC2.1 | Coeliac disease presenting with anti-OPG antibody mediated childhood osteoporosis and response to bisphosphonate therapyDavid Lim (Southampton, UK) |
| 12:15 | OC2.2 | The missing segment from the age of enlightenmentEmily Cottrell (London, UK) |
| 12:30-12:40 | | CSAC Trainee Representative UpdateChair(s):Katherine Hawton (Bristol, UK) & Rachel Boal (Newcastle, UK)Hall 1A |
| 12:40-13:30 | | Lunch Hall 1C & 1D |
| 13:30-14:30 | | CME Session 3Chair(s):Dinesh Giri (Bristol, UK) & Harriet Gunn (London, UK)Hall 1A |
| 13:30 | | Estrogen replacement in girls with Primary ovarian insufficiencyNaomi Crouch (Bristol, UK) |
| 14:00 | | Approach to hypogonadism in adolescent boys Gary Butler (London, UK) |
| 14:30-15:00 | | CME Case Presentations 3Chair(s):Dinesh Giri (Bristol, UK) & Harriet Gunn (London, UK)Hall 1A |
| 14:30 | OC3.2 | Two cases on the Carney Complex spectrum secondary to PRKACA/PRKAR1A variants presenting with Cushing Syndrome in childhoodMeera Shaunak (UCL Great Ormond Street Institute of Child Health, London, UK) |
| 14:45 | OC3.1 | A rare form of ovotesticular difference of sex development (DSD) in combination with severe early-onset obesity due to MC4R mutation: Clinical features and diagnostic challengesKatherine Hawton (Bristol, UK) |
| 15:00-15:30 | | BreakHall 1C & 1D |
| 15:30-16:00 | | CME Session 4Chair(s):Dinesh Giri (Bristol, UK) & Rachel Boal (Newcastle, UK)Hall 1A |
| 15:30 | | An approach to dynamic stimulation tests with challenges and pitfallsGuftar Shaikh (Glasgow, UK) |
| 16:00-16:30 | | CME Case Presentations 4Chair(s):Dinesh Giri (Bristol, UK) & Rachel Boal (Newcastle, UK)Hall 1A |
| 16:00 | OC4.1 | Pseudohypoaldosteronism case seriesRhiannon McBay-Doherty (Belfast, UK) |
| 16:15 | OC4.2 | Treatment-induced neuropathy of diabetes: A case reportMartha McKenna (Belfast, Northern Ireland) |
| 16:30-16:45 | | CME Officer's Update & ConclusionChair(s):Dinesh Giri (Bristol, UK)Hall 1A |
| 17:00-18:00 | | Industry Sponsored Satellite SymposiumFor more information please refer to the Industry Sponsored ProgrammeHall 1A |
| 17:00-18:00 | | Industry Sponsored Satellite SymposiumFor more information please refer to the Industry Sponsored ProgrammeHall 1B |
| 18:00-19:00 | | Welcome ReceptionHall 1C & 1D |
03 November 2022 |
| 08:00-08:45 | | Industry Sponsored Satellite SymposiumFor more information please refer to the Industry Sponsored ProgrammeHall 1A |
| 08:45-09:00 | | BreakHall 1C & 1D |
| 09:00-09:10 | | Welcome and IntroductionChair(s):Tabitha Randell, Nottingham (BSPED President) Senthil Senniappan, Liverpool (POC Chair) Noina Abid, Belfast (Local Convenor)Hall 1A |
| 09:10-10:40 | | Endocrine Oral Communications 1Chair(s):Charlotte Elder (Sheffield, UK) & Evelien Gevers (London, UK)Hall 1A |
| 09:10 | OC5.1 | Can lymphocyte subsets and B cell cytokines predict clinical response to Rituximab in paediatric Graves’ disease?Laura Lane (Newcastle, UK) |
| 09:20 | OC5.2 | Central Delayed puberty in Adolescence: Differentiating the phenotypes of Congenital Hypogonadotropic Hypogonadism and Self-Limited Delayed Puberty.Vasilis Kokotsis (London, UK) |
| 09:30 | OC5.3 | UK Protocol for Induction of Puberty with Gonadotropins in Males with Hypogonadotropic HypogonadismSasha Howard (Queen Mary University of London and Barts Health NHS Trust, London, UK) |
| 09:40 | OC5.4 | Greater Postnatal Adiposity Gain Following Inadequate Fetal Growth in The Manchester BabyGRO StudyReena Perchard (University of Manchester, Manchester, UK) |
| 09:50 | OC5.5 | The lack of genotype:phenotype correlations in rare causes of primary adrenal insufficiency highlights the need for genetic testingSaptarshi Maitra (London, UK) |
| 10:00 | OC5.6 | Prevalence of overweight and obesity in children with bone fragility and its correlation with disease severity and fracture rateAnjitha Anilkumar (Birmingham, UK)Anjitha AnilkumarSuma Uday ((Birmingham, UK)) |
| 10:10 | OC5.7 | Salivary Cortisol and Cortisone in Healthy Children and Young PeopleSilothabo Dliso (Liverpool, UK) |
| 10:20 | OC5.8 | SGPL1 deficiency impairs Leydig cell steroidogenesis and should be considered in 46XY individuals with DSD and adrenal insufficiencyRuth Ming Wai Kwong (London, UK) |
| 10:30 | OC5.9 | Evaluation Of A Low Postnatal Hypoglycaemia ThresholdPon Ramya Gokul (Alder Hey Children's Hospital, Liverpool, UK) |
| 09:10-10:40 | | Diabetes and Covid Symposium Chair(s):Tony Hulse (London, UK) & Rachel Besser (Oxford, UK)Hall 1B |
| 09:10 | | Introduction and the South East Thames StudyTony Hulse (Maidstone, UK) |
| 09:20 | | ‘DIMPLES’: Children presenting with diabetes and diabetic ketoacidosis to Emergency Departments during the COVID-19 pandemic in the UK and Ireland: a multicentre retrospective observational studyCaroline Ponmani (London, UK) |
| 09:40 | | ‘DIMPLES’: the Irish dimension Michael Barrett (Dublin, Republic of Ireland) |
| 09:50 | | ‘Proving Causation?’: antibody studies in Covid related DiabetesRachel Beckett (Belfast, Northern Ireland) |
| 10:00 | | Obesity and Type 2 diabetes and Covid Ankit Khanna (London, UK) |
| 10:15 | | 'What does all this mean?’ A panel discussion and Q&A session including Dr. Colin Dayan and chaired by Dr.Rachel BesserRachel Besser (Oxford University Hospitals NHS Foundation Trust, Oxford, UK) |
| 09:10-10:40 | | Endocrine Nurses' Business MeetingChair(s):Lee Martin (London, UK) & Angela McCormick (Belfast, UK)Meeting Room 1 |
| 10:40-11:10 | | BreakHall 1C & 1D |
| 11:10-12:10 | | Endocrine Symposium 1Chair(s):Renuka Dias (Birmingham, UK) & Pooja Sachdev (Nottingham, UK)Hall 1A |
| 11:10 | | Congenital Imprinting DisordersClaire Power (Dublin, Republic of Ireland) |
| 11:40 | | Consensus Guidelines for the management of Grave's dieseaseTim Cheetham (Newcastle, UK) |
| 11:10-12:10 | | Diabetes Symposium 2Chair(s):Anuja Natarajan (Doncaster, UK) & Noina Abid (Belfast, Northern Ireland)Hall 1B |
| 11:10 | | Impact of Diabetes Ketoacidosis on glycaemic controlEdna Roche (Dublin, Republic of Ireland) |
| 11:40 | | The big fat question - lipids and glycaemiaSusan O'Connell (Dublin, Republic of Ireland) |
| 12:10-12:40 | | Endocrine Oral Communications 2Chair(s):Christina Wei (London, UK) & Catherine Peters (London, UK)Hall 1A |
| 12:10 | OC6.1 | Pubertal staging examinations: A national survey of current practice in consent and chaperone useRebecca Moon (Southampton, UK) |
| 12:16 | OC6.2 | The Arginine-nitric-oxide Pathway Links Suboptimal Fetal Growth to Higher Childhood Systolic Blood Pressure in The Manchester BabyGRO StudyReena Perchard (University of Manchester, Manchester, UK) |
| 12:22 | OC6.3 | Use of 24 weekly Decapeptyl SR in Central Precocious Puberty is Well-Tolerated and Efficacious – A Two Centre StudyLydia Lake (London, UK) |
| 12:28 | OC6.4 | A Collaborative Community based Approach in providing Support for Children and Young People with Severe ObesityLouise Apperley (Alder Hey Children's Hospital, Liverpool, UK) |
| 12:34 | OC6.5 | Bone Mineralisation as Assessed by Bone Health Index in Children with Congenital Adrenal HyperplasiaHannah Francesca Roberts (Manchester, UK)Hannah Francesca RobertsProf. Raja Padidela (Manchester, (Manchester, UK)UK) |
| 12:10-12:40 | | Diabetes Oral Communications 1Chair(s):Melanie Kershaw (Birmingham, UK) & Fiona Campbell (Leeds, UK)Hall 1B |
| 12:10 | OC7.1 | Comparison of outcomes of the hybrid closed loop therapy with the conventional insulin pump in the first year after pump initiationNagapratheek Gopalakrishna (Sheffield, UK) |
| 12:16 | OC7.2 | Self-collection of capillary blood samples at home for HbA1c measurements during the COVID-19 pandemic in children with diabetes mellitusRachel Qian Hui Lim (London, UK)Rachel Qian Hui LimNikita Gireesh Bhat (London, (London, UK)UK)Rachel Qian Hui LimNikita Gireesh BhatPratik Shah (London, (London, (London, UK)UK)UK)Rachel Qian Hui LimNikita Gireesh BhatPratik ShahEvelien Gevers (London, (London, (London, (London, UK)UK)UK)UK) |
| 12:22 | OC7.5 | Monogenic obesity is probably not so rare - experience from a large tier 3 paediatric weight management serviceKatherine Hawton (Bristol, UK) |
| 12:28 | OC7.4 | Type A insulin resistance syndrome presenting with PCOS features and an unusual pattern of diabetes in a 10-year-old femaleSusmita Nath (London, UK) |
| 12:34 | OC7.3 | Hypogonadism and pubertal disorders in Wolfram SyndromeRenuka Dias (Birmingham Women’s and Children’s NHS Foundation Trust , Birmingham, UK) |
| 12:40-13:10 | | Industry Sponsored Expert Insights SessionFor more information please refer to the Industry Sponsored ProgrammeHall 1A |
| 12:40-13:10 | | Industry Sponsored Expert Insights SessionFor more information please refer to the Industry Sponsored ProgrammeHall 1B |
| 13:10-14:10 | | Lunch and Poster ToursHall 1C & 1D |
| 14:10-14:40 | | Awards Session - James M Tanner AwardChair(s):Tabitha Randell (Nottingham, UK)Hall 1A |
| 14:10 | | New abstractMartin Savage (UK) |
| 14:40-15:40 | | Diabetes Symposium 3Chair(s):Toby Candler (Bristol, UK) & Tabitha Randell (Nottingham, UK)Hall 1B |
| 14:40 | | Screening for Type 1 Diabetes - the ELSA studyParth Narendran (Birmingham, UK) |
| 15:10 | | Immunotherapy in diabetes - preservation of beta cellsColin Dayan (Cardiff, Wales) |
| 14:40-15:40 | | Endocrine Symposium 2Chair(s):Shankar Kanumakala (Brighton, UK) & Senthil Senniappan (Liverpool, UK)Hall 1A |
| 14:40 | | BSPED consensus guidelines: Emergency and peri-operative management of adrenal insufficiency in children and young peopleTalat Mushtaq (Leeds Teaching Hospitals NHS Trust, Leeds, UK)Talat MushtaqHoong-Wei Gan (Great Ormond Street Hospital, London, (Leeds Teaching Hospitals NHS Trust, Leeds, UK)UK) |
| 15:10 | | UK Consensus Guidelines for Hyperinsulinism ManagementGuftar Shaikh (Glasgow, UK) |
| 15:40-15:50 | | BreakHall 1C & 1D |
| 15:50-16:50 | | Personal Practice SessionChair(s):Ved Bhushan Arya (London, UK) & Bindu Avatapalle (Cardiff, UK)Hall 1B |
| 15:50 | | Long acting growth hormone Phil Murray (Manchester, UK) |
| 16:20 | | Structured education programme for Type 1 Diabetes in Northern IrelandAndrea McDougall (Belfast, Northern Ireland)Andrea McDougallJacqueline McVeigh (Belfast, (Belfast, Northern Ireland)Northern Ireland) |
| 15:50-16:20 | | Endocrine Oral Communications 3Chair(s):Ritika Kapoor (London, UK) & Tim Cheetham (Newcastle, UK)Hall 1A |
| 15:50 | OC8.1 | Do we need earlier thyroid surveillance amongst PTEN patients in the UK?Abhidhamma Kaninde (Brimingham, UK) |
| 15:56 | OC8.2 | Endocrine Effects of MEK and BRAF Inhibitor Therapy in Paediatric Patients: A Tertiary Centre ExperienceArif Hanafi Bin Jalal (London, UK) |
| 16:02 | OC8.3 | Characterisation of the first heterozygous missense HMGA2 variant helps delineate the crucial functional roles of a novel growth geneEmily Cottrell (London, UK) |
| 16:08 | OC8.4 | A national survey of bone-endocrine monitoring in Duchenne muscular dystrophy and the patients’ experienceSze Choong Wong (University of Glasgow, Glasgow, UK) |
| 16:14 | OC8.5 | Contrast media-induced hypothyroidismAlaa Baioumi (Bristol, UK) |
| 17:00-18:00 | | AGM (BSPED members only)Hall 1A |
| 19:30-00:00 | | Conference DinnerBelfast City Hall |
04 November 2022 |
| 09:30-11:00 | | Diabetes Symposium 4 Chair(s):Nicola Bridges (London, UK) & Louise Denvir (Nottingham, UK)Hall 1A |
| 09:30 | | Interpreting continuous glucose monitoringHannah Forde (Dublin, Republic of Ireland) |
| 10:00 | | Interpreting close loop pump downloadsJulia Ware (Cambridge, UK) |
| 10:30 | | Developing an early stage treatment for diabetic retinopathyTim Curtis (Belfast, Northern Ireland) |
| 09:30-11:00 | | Nurses' Day for Endocrine Professionals (Endocrine Symposium 3)Chair(s):Lee Martin (London, UK) & Jackie McNaboe (Belfast, UK)Hall 1B |
| 09:30 | | CAH & Adolescent gynaecology – an MDT perspectiveHazel Learner (London, UK)Hazel LearnerLouise Williams (London, (London, UK)UK)Hazel LearnerLouise WilliamsPhilomena Dasilva (London, (London, (London, UK)UK)UK) |
| 10:30 | | CAH and adolescence - a parent's perspectiveJoanne Hall (Parent) |
| 11:00-11:30 | | BreakHall 1C & 1D |
| 11:30-13:00 | | Diabetes Oral Communications 2Chair(s):Mark Burns (Middleborough, UK) & Suma Uday (Birmingham, UK)Hall 1A |
| 11:30 | OC9.1 | Access and use of new technologies in diabetes care in patients that need an Interpreter compared to those that do notMekhala Ayya (Birmingham, UK) |
| 11:40 | OC9.2 | Audit of Management of Diabetic Ketoacidosis in Children at the Noah's Ark Children's Hospital for WalesNagla Ahmed (Cardiff, UK)Nagla AhmedAmbika Shetty (Cardiff, (Cardiff, UK)UK) |
| 11:50 | OC9.3 | Diabetes and obesity in Down Syndrome across the lifespan: a retrospective cohort study using UK electronic health recordsAisha Aslam (London, UK) |
| 12:00 | OC9.4 | Do the UK’s commercially available real-time continuous glucose monitoring devices have robust accuracy data for paediatrics?John Pemberton (Birmingham, UK) |
| 12:10 | OC9.5 | Raising Awareness of the Importance of Preconception Counselling in Young People with DiabetesSteve Green (London, UK)Steve GreenVictoria Dublon (London, (London, UK)UK) |
| 12:20 | OC9.6 | A review of patient outcomes and responses to weight management strategies used by Complications from Excess Weight service, a new paediatric, hospital-based weight management serviceZainab Lunat (Manchester, UK) |
| 12:30 | OC9.7 | Liraglutide for the treatment of severe obesity in children: early experiences from a tier 3 paediatric weight management serviceKatherine Hawton (Bristol, UK) |
| 12:40 | OC9.8 | Cyclic improvement of a structured education programme teaching dynamic glucose management strategies in children and young people with type 1 diabetes using Continuous Glucose MonitoringJohn Pemberton (Birmingham, UK) |
| 11:30-12:30 | | Nurses' Day for Endocrine Professionals (Oral Communications 4)Chair(s):Lee Martin (London, UK) & Jackie McNaboe (Belfast, UK)Hall 1B |
| 11:30 | OC10.1 | Hormone Replacement Therapy in Paediatric Turner Syndrome – Evaluation of Current Practice in a Dedicated Paediatric Turner Clinic and Subsequent Development of Patient ResourcesGabriella Mackie (Glasgow, UK) |
| 11:40 | OC10.2 | Patient and parent experiences with oral hydrocortisone formulations for adrenal insufficiencyNabil Boulos (Southampton, UK) |
| 11:50 | OC10.4 | Increasing Patient Adherence and reducing Drug Wastage: impact of a Personalised Patient Support Programme integrated with a digital connect ecosystemAnne Marie Larkin (Dublin, Ireland) |
| 12:00 | OC10.5 | Factors affecting the hypoglycaemic response in the Insulin Tolerance Test in paediatric patientsYu Xiao (Cambridge, UK) |
| 12:10 | OC10.6 | A comparative study observing the association between Graves’ disease and the Covid-19 pandemic in childrenKamalpreet Uppal (Cardiff, UK) |
| 12:20 | OC10.3 | Development and testing of a novel ‘GrowthMonitor’ Smartphone App for growth monitoring and the detection of growth disordersThilipan Thaventhiran (London, UK) |
| 12:30-13:00 | | Presentations from Previous Award WinnersChair(s):Li Chan (London, UK) & Nadia Amin (Leeds, UK)Hall 1B |
| 12:30 | | Bone health in Type 1 Diabetes: The Key Determinants of Skeletal Fragility and the Role of Metformin Suet Ching Chen (Glasgow, UK) |
| 13:00-13:45 | | Lunch and Poster ToursHall 1C & 1D |
| 13:45-14:15 | | Industry Sponsored Expert Insights SessionFor more information please refer to the Industry Sponsored ProgrammeHall 1A |
| 14:15-15:45 | | Diabetes Symposium 5Chair(s):David McGregor (Devon, UK) & Zainaba Mohamed (Birmingham, UK)Hall 1A |
| 14:15 | | Conflict & Collaboration in Diabetes ManagementVincent McDarby (Dublin, Republic of Ireland) |
| 14:45 | | Diabetes in toddlers - practicalities and challengesTabitha Randell (Nottingham, UK) |
| 15:15 | | How to create and adapt exercise plans when using Continuous Glucose Monitoring (CGM) and Automated Insulin Delivery Systems (AID) with type 1 diabetesJohn Pemberton (Birmingham, UK) |
| 14:15-15:45 | | Nurses' Day for Endocrine Professionals (Endocrine Symposium 4)Chair(s):Martha Ford-Adams (London, UK) & Mars Skae (Manchester, UK)Hall 1B |
| 14:15 | | Immune dysregulation driving future risk of disease in children with obesityAndy Hogan (Dublin, Republic of Ireland) |
| 14:45 | | Non-alcoholic fatty liver diseaseSanjay Rajwal (Leeds, UK) |
| 15:15 | | Paediatric Endocrinology in ArtJeremy Kirk (Birmingham, UK) |
| 15:45-16:00 | | BSPED 2022 Awards SessionChair(s):Senthil Senniappan (Liverpool, UK) & Nadia Amin (Leeds, UK)Hall 1A |
| 16:00-16:15 | | Close of MeetingChair(s):Senthil Senniappan, POC Chair (Liverpool, UK)Hall 1A |